Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Palosuran (ACT-058362) (ACT-058362) is a new potent and specific antagonist of the human UT receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 59.00 | |
2 mg | In stock | $ 106.00 | |
5 mg | In stock | $ 212.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 483.00 | |
50 mg | In stock | $ 691.00 | |
100 mg | In stock | $ 983.00 | |
500 mg | In stock | $ 1,960.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 212.00 |
Description | Palosuran (ACT-058362) (ACT-058362) is a new potent and specific antagonist of the human UT receptor. |
Targets&IC50 | UT receptor (human):3.6±0.2 nM |
Synonyms | ACT-058362 |
Molecular Weight | 418.53 |
Formula | C25H30N4O2 |
CAS No. | 540769-28-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Palosuran 540769-28-6 Endocrinology/Hormones GPCR/G Protein GPR urotensin ACT-058362 Inhibitor ACT058362 ischemia diabetic UT receptor reperfusion Urotensin Receptor renal inhibit ACT 058362 pancreatic inhibitor